{
    "id": 2738,
    "fullName": "CIRBP dec exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "CIRBP dec exp indicates decreased expression of the Cirbp protein. However, the mechanism causing the decreased expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1153,
        "geneSymbol": "CIRBP",
        "terms": [
            "CIRBP",
            "CIRP"
        ]
    },
    "variant": "dec exp",
    "createDate": "12/12/2014",
    "updateDate": "10/08/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1456,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the siRNA-mediated down-regulation of the cold shock protein genes like CIRBP reduced cell growth in the absence of heat application and enhanced the chemosensitivity in prostate cancer cell lines to Adriamycin (doxorubicin) and Platinol (cisplatin) (PMID: 19277990)",
            "molecularProfile": {
                "id": 2560,
                "profileName": "CIRBP dec exp"
            },
            "therapy": {
                "id": 700,
                "therapyName": "Cisplatin",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1214,
                    "pubMedId": 19277990,
                    "title": "Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19277990"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1457,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the siRNA-mediated down-regulation of the cold shock protein genes like CIRBP reduced cell growth in the absence of heat application and enhanced the chemosensitivity in prostate cancer cell lines to Adriamycin (doxorubicin) and Platinol (cisplatin) (PMID: 19277990)",
            "molecularProfile": {
                "id": 2560,
                "profileName": "CIRBP dec exp"
            },
            "therapy": {
                "id": 1009,
                "therapyName": "Doxorubicin",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1214,
                    "pubMedId": 19277990,
                    "title": "Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19277990"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2560,
            "profileName": "CIRBP dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}